Takeda to vault into Big Pharma with $62B Shire buyout—and megamerger cuts are on the way
admin 8th May 2018 Uncategorised 0Shire and Takeda have finally, officially, agreed on a deal. The Japanese drugmaker will shell out $62 billion on the rare disease specialist, almost half of that in cash. Now, it’ll be up to Takeda to make the buyout pay, and it’s eyeing $1.4 billion in cost cuts—including some 3,600 jobs— to help do that.
More: Takeda to vault into Big Pharma with B Shire buyout—and megamerger cuts are on the way
Source: fierce